Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Net Income (2016 - 2025)

Historic Net Income for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to -$3.2 million.

  • Lipocine's Net Income fell 4362.75% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 3498.83%. This contributed to the annual value of $8352.0 for FY2024, which is 10005.11% up from last year.
  • As of Q3 2025, Lipocine's Net Income stood at -$3.2 million, which was down 4362.75% from -$2.2 million recorded in Q2 2025.
  • Over the past 5 years, Lipocine's Net Income peaked at $12.6 million during Q4 2021, and registered a low of -$6.8 million during Q2 2021.
  • Moreover, its 5-year median value for Net Income was -$2.6 million (2022), whereas its average is -$1.8 million.
  • In the last 5 years, Lipocine's Net Income surged by 37983.26% in 2021 and then plummeted by 17606.95% in 2023.
  • Lipocine's Net Income (Quarter) stood at $12.6 million in 2021, then plummeted by 117.66% to -$2.2 million in 2022, then dropped by 2.35% to -$2.3 million in 2023, then surged by 178.09% to $1.8 million in 2024, then crashed by 278.82% to -$3.2 million in 2025.
  • Its Net Income stands at -$3.2 million for Q3 2025, versus -$2.2 million for Q2 2025 and -$1.9 million for Q1 2025.